# 2026-12144: Pharmacy Requests Permit for Elephant Tranquilizer Imports

2026-12144, Importer of Controlled Substances Application: Wedgewood Pharmacy LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-06-17, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 17, 2026. Such persons may also file a written request for a hearing on the application on or before July 17, 2026.; PRIA reads it as touching household money (as of 2026-06-24).

- Canonical: https://policyrisk.com/federal-register/2026-12144
- As of: 2026-06-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12144
- Title: Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 36619
- Published: 2026-06-17
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 17, 2026. Such persons may also file a written request for a hearing on the application on or before July 17, 2026.
- Comments close: 2026-07-17
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-24

## In one line

Pharmacy Requests Permit for Elephant Tranquilizer Imports

## Summary

Wedgewood Pharmacy LLC wants to become an official importer of certain strong controlled substances, like Etorphine HCL and Thiafentanil. This affects drug manufacturers and others in the supply chain who can comment or request a hearing by July 17, 2026. No direct costs are mentioned, but the decision could impact how these drugs enter the U.S. market.

## Abstract

Wedgewood Pharmacy LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- Application to Import Two Schedule II Drugs: mixed, low. Wedgewood Pharmacy LLC applied on May 5, 2026 to be registered as an importer of Etorphine HCL (drug code 9059) and Thiafentanil (drug code 9729), both listed as Schedule II controlled substances. The application states the company plans to import these substances for distribution to their customer…
- Deadline to Comment or Request Hearing: benefit, low. Registered bulk manufacturers of the listed drug classes and other applicants may submit electronic comments or objections, or file a written request for a hearing, on or before July 17, 2026 via https://www.regulations.gov or by delivering hearing requests to DEA addresses listed in the notice. Su…
- Import Authorization Is Limited: cost, low. The notice states that, if registered, Wedgewood's authorization would be limited to importing the listed drug codes for distribution to customers and would not authorize any other activities. Approval would not extend to importation of FDA-approved or non-approved finished dosage forms for commerc…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-12144 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/17/2026-12144/importer-of-controlled-substances-application-wedgewood-pharmacy-llc)
- [2026-12144 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-17/pdf/2026-12144.pdf)

## Related
- [Previous: 2026-12143, Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pha…](https://policyrisk.com/federal-register/2026-12143)
- [Next: 2026-12145, Civilian Acquisition Workforce Personnel Demonstration (AcqDemo) Project; Depar…](https://policyrisk.com/federal-register/2026-12145)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12144 (as of 2026-06-24).